Join us for this 2nd Meeting on Epigenetics and Epigenomics in Health and Disease:

25th-26th September 2025, Brussels

WELCOMING ACADEMIA, HEALTH & INDUSTRY

CONFIRMED SPEAKERS:

1. • Tony Kouzarides, University of Cambridge, UK
2. • Ali Shilatiffard, University of Chicago, USA
3. • Shelley Berger, University of Pennsylvania, USA
4. • Ramin Shiekhattar, University of Miami, USA
5. • Luciano Di Croce, Center for Genomic Regulation, Spain
6. • Michael Kharas, Memorial Sloan Kettering, USA
7. • Cigall Kadosh, Harvard, USA
8. • Navdeep Chandel, University of Chicago, USA
9. • Geneviève Almouzni, Curie Institute, Paris
10. • Lluis Morey, University of Miami, USA
11. • Ernesto Guccione, Sinai Institute, USA
12. • Or Gozani, Stanford, USA
13. • Mathieu Lupin, McGill, Canada
14. • Alex Meissner, Max Planck Institute, Germany
15. • Yael David, Memorial Sloan Kettering, USA

Scientific Organizer:

Prof. François Fuks

Laboratory of Cancer Epigenetics

Université libre de Bruxelles (ULB)

Faculty of Medicine, Brussels

Topics include: DNA and histone modifications,

RNA Epigenetics, non-coding RNA, Epigenomic tools & more…

For more information, please contact:

francois.fuks@ulb.be

In partnership with XCELLS Conferences, we are excited to announce that we will be back in

Brussels next year for the 2nd meeting on “Epigenetics and Epigenomics in Health and Disease” (25th

26th September 2025). This international forum will gather some of the most prominent speakers in the

field, coming from the top universities around the world to highlight the most recent findings on the

mechanisms and physiopathological roles of epigenetics modification in the development of diseases,

including cancer.

This meeting will gather scientists, pharmaceutical companies and physicians working in

different fields but sharing the same interests. The structure of this two-day conference will include

several oral and poster presentations and technological workshops presenting an ideal opportunity for

its attendees to meet, discuss and summarize the advances in this fast evolving field.

We will also have speakers from industries. There will also be slots for company presentations,

would you find this opportunity of interest to you. 

We anticipate a high turnout of participants, as this

conference will offer a unique networking opportunity. We had over 250 participants in the 1st edition

of the meeting in 2022. Given the extremely positive feeback we received from this first edition, we

anticipate an even higher number of attendees for the 2025 meeting.

https://www.cellclassifier.org/blog/scfast-seq-74/seekone-r-dd-single-cell-full-lengthrnasequence-transcriptome-seq-scfast-seq-7